| Notice Filed with SOS |
10/30/2020 |
| Rule |
ProposedRuleAttach2020-00858.doc |
| Statutory Authority |
26-1-107, C.R.S. (2019); 26-1-109, C.R.S. (2019); 26-1-111, C.R.S. (2019); 18-18-301, C.R.S. (2019); 27-80-204, C.R.S. (2019); 27-80-213, C.R.S. (2019); 42 C.F.R. Part 8 |
| Description of Subjects/Issues |
Pursuant to the Colorado Licensing of Controlled Substances Act, a substance use disorder (SUD) program that compounds, administers, or dispenses a controlled substance must annually obtain a controlled substance license from the Office of Behavioral Health (OBH). Senate Bill 19-219 continued the Colorado Licensing of Controlled Substances Act and this rule update aligns OBH’s controlled substance licensing rules with the changes to controlled substance licensing from SB 19-219. The rule update also clarifies inconsistencies within the controlled substance licensing and opioid treatment program regulations, including confirming that an office-based opioid treatment program does not need an OBH-issued controlled substance license in order to operate in Colorado. The goal of this rule update is to promote rules that are efficient and effective to ensure individuals in Colorado have access to safe and effective medication assisted treatment options. |
| Purpose/Objective of Rule |
Pursuant to the Colorado Licensing of Controlled Substances Act, a substance use disorder (SUD) program that compounds, administers, or dispenses a controlled substance must annually obtain a controlled substance license from the Office of Behavioral Health (OBH). Senate Bill 19-219 continued the Colorado Licensing of Controlled Substances Act and this rule update aligns OBH’s controlled substance licensing rules with the changes to controlled substance licensing from SB 19-219.
The rule update also clarifies inconsistencies within the controlled substance
licensing and opioid treatment program regulations, including confirming that an
office-based opioid treatment program does not need an OBH-issued controlled
substance license in order to operate in Colorado. The goal of this rule update is to promote rules that are efficient and effective to ensure individuals in Colorado
have access to safe and effective medication assisted treatment options. |
| Basis And Purpose |
BasisAndPurposeAttachment2020-00858.doc
|
| Regulatory analysis |
RegulatoryAnalysisAttachment2020-00858.doc
|
| Comments |
CDHS holds two public hearings, an initial and final, for each proposed rule packet. The initial hearing allows the public an opportunity to submit written data, views, or arguments and to testify for or against the proposed rules. The Board does not vote on the proposed rule at the initial hearing, but asks CDHS to consider all public comment and discussion and, if needed, submit revisions to the proposed rule. The final hearing, usually the month following the initial hearing, allows the same opportunity for public comment, after which the Board votes on final adoption of the proposed rule. NOTE: Due to the ongoing COVID-19 situation, it is anticipated that this meeting will take place entirely online. Please check here for any updates on location/connection: https://cdhs.colorado.gov/sbhs |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
Yes
|
| Recent legislation bill number |
SB 19-219
|
| Hearing Date |
12/04/2020 |
| Hearing Time |
08:30 AM |
| Hearing Location |
Location Pending State's response to COVID-19. Likely to be held entirely online. |
| Contact Name |
Ryan Templeton |
| Contact Title |
Policy Advisor |
| Contact Telephone |
303-866-7405 |
| Contact email |
ryan.templeton@state.co.us |